Bills › 89th General Assembly
Relating to controlled substances, including amending the controlled substance schedules and information collection and reporting requirements under the Iowa prescription monitoring program, and including effective date provisions
Sponsored by the Senate Judiciary Committee
Topics:State governmentHealth care
Where it is now
- Done: IntroducedJanuary 27, 2022
- Done: SubcommitteeJanuary 31, 2022
- Done: Senate committeeFebruary 8, 2022
- Done: Passes the SenateApril 12, 202248–0
- Skipped: House committeeSkipped
- Done: Passes the HouseFebruary 22, 202294–1
- Done: To the GovernorMay 2, 2022
- Done: Signed into lawMay 2, 2022
HF 2201 became law → The same legislation passed as HF 2201, so this version was set aside. Go to HF 2201 What’s a funnel?
What’s in it
AI summary This bill updates how Iowa lists certain drugs and chemicals to match federal rules. It also changes how the group that advises the state on prescription monitoring is chosen and organized. This new group will have more responsibility to protect patient privacy and civil liberties.1
Read the official explanation
This bill relates to controlled substances, including amending the controlled substance schedules and information collection and reporting requirements under the Iowa prescription monitoring program, and including effective date provisions. DIVISION I —— CONTROLLED SUBSTANCE SCHEDULES —— PRECURSOR SUBSTANCES REPORTING.), parts 1300, 1308, and 1310. The division takes effect upon enactment. DIVISION II —— IOWA PRESCRIPTION MONITORING PROGRAM. This division amends the composition and appointment of the Iowa prescription monitoring program advisory council. The bill changes the advisory council from a governor-appointed council to a board-appointed council; removes the minimum number of council members; modifies the composition of the council; directs the board to adopt rules on matters pertaining to council membership including terms of appointment and quorum; requires the board to consult with professional organizations and licensing boards for counsel membership; and expands the responsibility of the council to monitor and ensure that patient confidentiality, best interests, and civil liberties are at all times protected and preserved during the existence of the prescription monitoring program.
Senate subcommittee
Named January 31, 2022 (as SSB 3073). On February 2, 2022 it recommended passage.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Iowa Code it changes
Lobbying
4 for · 0 against · 16 undecided · Who →
Family tree
Study bill
89th General Assembly